The Lancet Neurology has featured a review on levodopa-induced dyskinesias in patients with Parkinson’s disease. The review discusses recent preclinical findings from rodent and primate models of levodopa-induced dyskinesia, as well as recent clinical data from patients with Parkinsons disease, focusing on dopaminergic and non-dopaminergic mechanisms underlying these involuntary movements.